Medication-info.com Search Menu

Rowasa (Mesalamine): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
4 g/60 mL
Other brand names:
Drug class:
Active ingredient:
Similar drugs:

Patient information: uses, side effects, how to take - Rowasa

INSTRUCTIONS FOR USE

ROWASA [ro wa sa]

(mesalamine)

rectal suspension

This Instructions for Use contains information on how to use ROWASA rectal suspension. Read these Instructions for Use that come with your ROWASA rectal suspension before you start using it and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.

How should I Store ROWASA?

  • Store ROWASA at room temperature between 68°F to 77°F (20°C to 25°C).
  • ROWASA is an off-white to tan colored suspension. The medicine removed from the foil pouch may darken with time. Slight darkening will not affect how well ROWASA works.
  • Throw away ROWASA rectal suspensions with dark brown medicine.
  • Keep ROWASA and all medicines out of the reach of children.

Important Information You Need to Know Before Using ROWASA

  • ROWASA is for rectal use only.
  • Do not share ROWASA with other people, it may harm them.
  • If a caregiver is giving ROWASA make sure they read and understand these Instructions for Use.
  • Use ROWASA exactly as your healthcare provider tells you to use it.
  • It is recommended to use 1 ROWASA bottle each day.
  • After the foil wrapped unit of 7 bottles is opened, use each bottle of ROWASA rectal suspension right away.
  • Empty bowels right before the medicine is given.
  • Give at bedtime.
  • ROWASA will stain some surfaces including but not limited to fabrics, flooring, painted surfaces, marble, granite, vinyl, and enamel. Take care in choosing the right place for giving the ROWASA rectal suspension.

Preparing to use ROWASA

Step 1. Remove the bottles.

  • Remove all the bottles from the protective foil pouch by grasping at the seam and tearing downward or by using scissors at the top of the foil pouch (See Figure A).
  • Be careful not to squeeze or puncture bottles.

Step 2. Prepare to give the medicine.

  • Shake the first bottle well to make sure that the medicine is mixed well.
  • Remove the protective sheath from the applicator tip. Hold the bottle at the neck so as not to cause any of the medicine to be released (See Figure B).

Step 3. Get in position.

  • Lay on your left side with your left leg extended and your right leg flexed forward for balance (See Figure C).

or

  • Get in the knee-chest position as shown here (See Figure D).

Step 4. Giving the medicine.

  • Lubricate the applicator tip.
  • Gently insert the lubricated applicator tip into the rectum pointing slightly toward the belly button (navel) to prevent damage to the rectal wall.
  • Grasp the bottle firmly, then tilt slightly so that the nozzle is aimed toward the back.
  • Squeeze the bottle slowly to release the medicine into the rectum (See Figure E).
  • Steady hand pressure will release most of the medicine.
  • After giving the medicine, withdraw the applicator tip.
  • Remain in position for at least 30 minutes to allow the medicine to spread inside the body.
  • Throw away (discard) the bottle.
  • Try to keep the medicine inside your body all night, if possible.

IN-003606-08

Rev. 7/2024

Distributed by:

MEDA

PHARMACEUTICALS

Canonsburg, PA 15317 U.S.A.

© 2024 Viatris Inc.

ROWASA is a registered

trademark of Alaven Pharmaceutical LLC, a Viatris Company.

For Medical Inquiries, Call Toll Free:

1-866-210-5949

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 019618 · View the label on DailyMed

Revision date stated in the text: July 2024

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Rowasa

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Aminosalicylate
Active ingredient Mesalamine 4 g/60 mL
Dosage form Suspension
Route Rectal
Marketing status listed in the FDA NDC Directory
Company (applicant) MYLAN SPECIALITY LP
FDA approval NDA 019618New Drug Application (NDA) Approved December 24, 1987
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Therapeutic equivalence (TE) code ABCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
4 g/60 mL – 60 ml in 1 bottle, dispensing / 7 in 1 carton NDC 0037-0066-06
4 g/60 mL – 60 ml in 1 bottle, dispensing / 28 in 1 carton NDC 0037-0066-06

Source: FDA drug labeling via NLM DailyMed, data as of November 5, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.